Prevalence of potentially inappropriate medications among newly treated patients with type 2 diabetes in UK primary care

Feb-24

AUTHORS : Andrea M Burden, Institiute fro Pharmaceutical Sciences, Department of Chemistry and Applied Biosciences, ETH Zurich HCI H 407 Vladimir-Prelog-Weg4, 8093 Zürich, Switzerland, EMAIL; andrea.burden@pharma.ethz.ch

JOURNAL : British Journal ofClinical Pharmacology

REFERENCE: 2024;1-19

DOI : 10.1111/bcp.16018

Prevalence of potentially inappropriate medications among newly treated patients with type 2 diabetes in UK primary care

More publications

Glucose Lowering through Weight management (GLoW): a randomised controlled trial of the clinical and cost effectiveness of a diabetes education and behavioural weight management programme vs a diabetes education programme in adults with a recent diagnosis of type 2 diabetes

Characteristics, risk factors and clinical impact of penicillin and other antibiotic allergies in adults in the UK General Practice: a population-based cohort study

Increased risk of fracture among patients with iron overload: a population-based matched cohort study